Balloon Catheter

Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $1.94 billion in cash. 

Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon

The U.S. Food and Drug Administration (FDA) has cleared Medtronic’s In.Pact Admiral drug-coated balloon (DCB) for the interventional treatment of peripheral artery disease (PAD) for the superficial femoral and popliteal arteries in the upper leg....

C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approval of the Lutonix 035 drug-coated balloon (DCB) catheter for percutaneous transluminal angioplasty (PTA) after pre-dilatation, for the treatment of de novo or restenotic l...

Boston Scientific Corp. CE mark Ranger Ranger Paclitaxel-coated PTA Balloon Cath

Boston Scientific received CE mark for the Ranger Paclitaxel-coated PTA Balloon Catheter. The technology is now in full European market launch. 

Biotronik, Passeo-18 Lux, DCB, BIOLUX P-I, trial, drug eluting, balloon catheter
Biotronik announced that results of its BIOLUX P-I clinical study have been published in the Journal of Endovascular Therapy. BIOLUX P-I was a prospective,...
Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $...
In.PACT Admiral, PAD, Medicare, pass-through payment, Medtronic, balloon cath
Medtronic announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a transitional pass-through payment for the company’s IN.PACT...
Bard, Lutonix, drug coated balloon, DCB, CMS, pass-through payment, outpatient
C. R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has approved a pass-through payment for the Lutonix drug-coated...
Balloon catheters, Heart Valve repair, Cath Lab, Hybrid OR
Medtronic’s In.Pact Admiral drug-coated balloon (DCB) is for the interventional treatment of peripheral artery disease (PAD) for the...
The Lutonix 035 drug-coated balloon (DCB) catheter is for percutaneous transluminal angioplasty (PTA) after pre-dilatation, for the...

Articles

Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $...
Medtronic, In.Pact Admiral DEB, drug coated balloon, drug eluting balloon
Drug-eluting balloons (DEBs) have been one of the long-awaited new transcatheter technologies to help reduce high restenosis rates in peripheral artery disease...
drug-eluting balloons, DEB, ECRI, report, peripheral artery disease, PAD, cath
ECRI Institute has created a report that offers an overview of drug-eluting balloon (DEB) technology, “Health Technology Forecast report, "Drug-eluting...
Medtronic, In.Pact, Admiral drug-coated balloon, DCB, drug-eluting balloon, DEB
The U.S. Food and Drug Administration (FDA) has cleared Medtronic’s In.Pact Admiral drug-coated balloon (DCB) for the interventional treatment of peripheral...

Video Center

U.S. healthcare reform is largely being driven through adoption of new information technology (IT...
2 days 22 hours ago
The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual...
4 weeks 2 days ago
It’s been no secret that the American healthcare system needed to change to survive economically...
10 weeks 3 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...